A call out has been put out for volunteers to take part in the next stage of human trials for a promising COVID-19 vaccine candidate.
The vaccine, developed by University of Queensland researchers, has already been trialed on 120 Queenslanders aged between 18 and 55.
However, following the positive results from the first stage of testing, UQ has now been given approval to extend testing on people aged 56 and over.
ARTICLE CONTINUES AFTER THIS ADVERTISEMENT
Deputy Premier and Minister for Health Steven Miles said more than 4000 people put their hand up to take part in the first stage of the trial earlier this year.
“I offer my thanks to the Queenslanders who answered the call to take part in the first round of clinical trials,” he said.
“Today we’re putting the call out to another 96 Queenslanders aged 56 and over to take part in clinical trials.”
UQ vaccine project co-leader Professor Paul Young said the human trial was being expanded to help gauge the vaccine’s safety among an older demographic as well as the immune response elicited.
“As most people are now aware, COVID-19 appears to be more severe in older individuals,” he said.
“We’re looking to ensure that this vaccine candidate is safe for use in older people, and we’re hoping Queenslanders get behind us and sign up.”
The Phase 1 trial is being conducted at Nucleus Network’s Brisbane clinic.
There is no cost involved in attending the study, with those taking part reimbursed $2,300 for their time and inconvenience.
For more information and to apply to take part, click here.